Pakar Kista

Cyst Health, Explained

Breaking News
Ovarian Health

J&J launches Ottava robotic surgery system in Texas hospital

By Aurel Maulana November 21, 2026
J&J launches Ottava robotic surgery system in Texas hospital - robotic surgery system
The FDA approved Ottava in July for deployment in 10 general upper-abdominal surgeries, including gastric bypass, splenectomy, and hernia repair.

Johnson & Johnson has revealed that Memorial Hermann-Texas Medical Center will serve as the first U.S. hospital to commercially introduce its Ottava robotic surgery platform. This initiative advances J&J’s strategy to strengthen its position in the surgical robotics market, where it competes directly with Intuitive Surgical and faces growing challenges from Medtronic and other emerging players.

The FDA approved Ottava in July for deployment in 10 general upper-abdominal surgeries, including gastric bypass, splenectomy, and hernia repair. A defining feature of the system is its integration of four robotic arms directly into a standard operating table, resolving a persistent issue for hospitals: the shortage of space in operating rooms. This design also seeks to improve efficiency as demand for robotic-assisted procedures continues to rise.

Memorial Hermann-Texas played a role in Ottava’s clinical trials, which provided the evidence needed for FDA clearance. J&J will now distribute the system to additional U.S. hospitals while investigating further medical applications. Meanwhile, Medtronic expanded its Hugo robot’s FDA approval this week, extending its use from urological procedures to general abdominal surgeries.

The timing of Medtronic’s announcement coincides with Johnson & Johnson’s commercial launch of its Ottava platform at Memorial Hermann-Texas Medical Center. Both developments highlight the accelerating pace of innovation in robotic-assisted surgery, with manufacturers competing to address growing hospital demand for advanced surgical tools.

Medtronic’s Hugo Robot Expands FDA Approval for General Surgery

Medtronic received FDA clearance this week for its Hugo robot to perform upper abdominal general surgeries, broadening its initial approval for urological procedures. The expansion now includes operations such as prostate removal, which were previously covered under the robot’s initial clearance in December.

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 Pakar Kista. All rights reserved.